Skip to main content

Diabetes Technology

Blue Shield Rolls Out 2027 Medicare Plans With $0 Premiums, Rx Tools

Oakland, Calif. – October 01, 2026 -- Blue Shield of California has unveiled its 2027 Medicare plan lineup, giving eligible residents new coverage choices ahead of the Annual Enrollment Period running Oct. 15 through Dec. 7, 2026.

Plan options span Medicare Advantage to prescription-only coverage

The nonprofit insurer's portfolio includes Medicare Advantage plans, a Dual-Eligible Special Needs plan for those who qualify for both Medicare and Medi-Cal, Medicare Supplement plans, and stand-alone prescription drug plans. Members seeking flexibility can opt for Medicare Supplement plans, which allow access to any doctor nationwide who accepts Medicare.

BodySpec Opens Oakland Location for Under-$60 Muscle and Bone Scans

Oakland – September 30, 2026 -- BodySpec has opened a new storefront in downtown Oakland offering medical-grade DEXA body scans for under $60, giving East Bay residents a fast way to track muscle mass, visceral fat, and bone density as GLP-1 weight-loss drug use rises.

The 12-minute scan measures body fat, visceral fat, lean muscle mass, and bone density, paired with a digital dashboard and a conversational AI agent that explains results and suggests personalized next steps.

GLP-1 users risk losing muscle along with fat

One in 8 Americans currently uses a GLP-1 medication, and studies show 25 to 40 percent of weight lost on these treatments can be lean muscle rather than fat, according to BodySpec.

Meant Health Expands Telehealth Access to Ozempic and GLP-1 Prescriptions

Manassas – September 16, 2026 -- Meant Health has expanded its telehealth platform to connect patients with licensed U.S. clinicians for evaluation and prescription of FDA-approved GLP-1 medications, including Ozempic.

Patients start with an intake questionnaire before any prescription decision

The process begins with a questionnaire covering health history, current medications and treatment goals. A licensed clinician then reviews the submission and decides, case by case, whether a prescription is appropriate.

Ozempic is approved for type 2 diabetes, not weight loss

Ozempic carries FDA approval for treating type 2 diabetes. When clinicians prescribe it for weight management, that use is off-label and remains entirely at the clinician's discretion.

Free AI Eye Scan Aims to Close Diabetes Screening Gap in Germany

Berlin – September 11, 2026 -- Diabetes can silently damage the eyes years before patients notice any change in their vision, yet new data show barely half of people with type 2 diabetes get the recommended eye exam. To close that gap, German health insurer mkk - meine krankenkasse now offers its members a free eye screening from Skleo Health at participating opticians and drugstores.

About seven million adults in Germany live with known or undiagnosed diabetes, according to the Robert Koch Institute. One serious complication is diabetic retinopathy, damage to the tiny blood vessels in the retina caused by diabetes duration, high blood sugar, and hypertension. Retinal changes can develop long before someone experiences blurred vision or other symptoms.

Diabetic Cyclist Wins Climbing Title at Philadelphia Classic's Return

PHILADELPHIA -- September 01, 2026 -- David Lozano, a Spanish rider with type 1 diabetes, won the King of the Mountains classification at the Philadelphia Cycling Classic on Saturday, claiming the climber's jersey as America's most prestigious one-day race returned after a decade away. Lozano, who races for Team Novo Nordisk, the world's first all-diabetes professional cycling team, led the day's decisive breakaway over the Manayunk Wall and Lemon Hill. Teammate Filippo Ridolfo finished 12th, the team's top overall result on the day.